Randomized Placebo-Controlled Trial to Assess the Impact of Oral Naltrexone on HIV Treatment Outcomes Among HIV-1 Infected Men Who Have Sex with Men and Transgender Women with Alcohol Use Disorders in Lima, Peru, 2014-2015

The Seek, Test, Treat and Retain (STTR) Collaboration Project involved over twenty studies in the fields of HIV and drug abuse. These studies were independently developed, but were chosen for the collaboration because they focused on one or more steps of the HIV treatment cascade: Seek, Test, Treat and Retain. These studies were grouped into Criminal Justice-related studies and Vulnerable Population-related studies. The data collected by these studies included twelve common domains (e.g. demographic characteristics, mental health) in each of which a shared questionnaire or instrument was taken up by the studies and adapted to fit the study. This repository contains the collected data and documentation from the STTR collaboration.
This study in particular, assesses outcomes of Oral Naltrexone on HIV Treatment among HIV-1 infected men in Lima, Peru. A randomized blinded placebo-controlled clinical trial was conducted to determine if oral naltrexone (NTX) would improve the likelihood that HIV-infected participants with alcohol use disorders (AUDs) remain engaged in care and become highly adherent to antiretroviral therapy (ART), with acceptable safety.